wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34128953-0217F5F8-12D7-49A8-B6A6-B8E716817F34
Q34128953-0217F5F8-12D7-49A8-B6A6-B8E716817F34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34128953-0217F5F8-12D7-49A8-B6A6-B8E716817F34
Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer
P2860
Q34128953-0217F5F8-12D7-49A8-B6A6-B8E716817F34
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34128953-0217F5F8-12D7-49A8-B6A6-B8E716817F34
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a9b1d30adc1b81c0359284a7ff262e26199ba48c
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.